Friday December 1, 2017 |
08:00 | Registration |
|
08:50 | Opening |
Prof Piet HERDEWIJN (KU LEUVEN, Leuven, Belgium) |
09:00 | PL01 - 2’-Spiro-substituted Nucleosides Active against the Hepatitis C-virus |
Dr Tim JONCKERS (JANSSEN, Beerse, Belgium) |
09:50 | PL02 - Use of Cyclic Dinucleotides (CDNs) to Induce Stimulator of Interferon Genes (STING)-Dependent Antitumor Immunity |
Dr Cedric BOULARAN (INVIVOGEN, Toulouse, France) |
10:40 | Coffee break and Exhibition |
|
11:15 | OC01 - Unlock your Compound Management |
Dr Jan BREITENFELD (CHEMSPEED TECHNOLOGIES AG, Füllinsdorf, Switzerland) |
11:35 | PL03 - Discovery of Novel DOT1L Inhibitors by Fragment Growing, Defragmentation and Fragment Linking |
Dr Henrik MÖBITZ (NOVARTIS, Basel, Switzerland) |
12:25 | Lunch, Exhibition and Poster session |
|
14:00 | PL04 - Antitumoral and Antiviral Nucleosides, siRNAs and shRNAs for Applications in vitro, in vivo and in Bioprinted 3D Organ Models |
Prof. Jens KURRECK (UNIVERSITY OF BERLIN, Berlin, Germany) |
14:50 | OC02 - Novel 3'-Deoxy Purine Nucleoside Analogs as Highly Potent Leads for Human African Trypanosomiasis |
Dr Fabian HULPIA (UGENT, Beerse, Belgium) |
15:10 | OC03 - New Genetic Systems with Four Non-Canonical Nucleobases: Biotechnology and Therapeutic Applications |
Dr Elena EREMEEVA (KU LEUVEN, Leuven, Belgium) |
15:30 | Coffee break, Exhibition and Poster session |
|
16:05 | PL05 - Synthetic Genetics: Beyond DNA and RNA |
Dr Philipp HOLLIGER (MRC LABORATORY OF MOLECULAR BIOLOGY, Cambridge, United Kingdom) |
16:55 | PL06 - Large Scale Pooled Crispr Screening: Mining for the Deep |
Dr Roderick BEIJERSBERGEN (NETHERLANDS CANCER INSTITUTE, Amsterdam, The Netherlands) |
17:45 | Closing Remarks |
|